Raymond C. Wadlow, MD

Articles by Raymond C. Wadlow, MD

Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy

ByKhaled W. Kabbara, MD,Timothy Cannon, MD,Arthur Winer, MD,Raymond C. Wadlow, MD

August 19th 2022

Khaled W. Kabbara, MD, and colleagues, research treatment options for cholangiocarcinoma.

Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer

ByMarwan Al-Hajeili, MD,Anthony F. Shields, MD, PhD,Jimmy J. Hwang, MD,Raymond C. Wadlow, MD,John L. Marshall, MD

April 15th 2017

Recent improvements in our understanding of the biology of colorectal cancer have led to the identification of several important prognostic and predictive markers of disease-associated risk and treatment response for the individual patient.

Raymond C. Wadlow, MD

Articles by Raymond C. Wadlow, MD

Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy

Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer

Latest Updated Articles

Trending on CancerNetwork

NCCN Guidelines Add Novel Therapeutics to First-Line TNBC Armamentarium

BCMA-Directed Bispecific Antibodies Navigating a New Era in Relapsed/Refractory Multiple Myeloma

FDA Approves Nivolumab/AVD in Untreated Hodgkin Lymphoma

Emerging Strategies in Prostate Cancer: Molecular Glues and T-Cell Engagers

FDA Grants Orphan Drug Status to Irinotecan-ChemoSeed for Malignant Glioma